FDA appropriations
This article was originally published in The Tan Sheet
Executive Summary
Senate passes FDA appropriations bill (S 2159) by a vote of 97 to 2 July 16, providing FDA with $1.09 bil. in funding for fiscal 1999 (begins Oct. 1). The measure passed with an amendment co-sponsored by Sens. Dale Bumpers (D-Ark.) and Thad Cochran (R-Miss.) denying funds for preparing the fiscal year 2000 budget if it includes unauthorized user fees or does not identify spending cuts or revenue increases that should take place if the fees are not adopted. The companion bill (HR 4101) providing $1.01 bil in FDA FY 1999 appropriations passed the House June 24...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning